|Articles|October 14, 2019
Quantifying Quality Attributes of AAV Gene Therapy Vectors by SEC-UV-MALS-dRI
Author(s)Wyatt
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Genentech Expands RNAi Pipeline Through Global Licensing Deal
2
FAQ: What You Need to Know About Agentic AI in Drug Discovery
3
AstraZeneca’s $15 Billion Investment Deepens China R&D and Manufacturing Footprint
4
Coya Raises $11.1 Million to Advance Immunomodulatory ALS Program
5